249 related articles for article (PubMed ID: 10329920)
21. Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia.
Eisterer W; Bechter O; Söderberg O; Nilsson K; Terol M; Greil R; Thaler J; Herold M; Finke L; Günthert U; Montserrat E; Stauder R
Leuk Res; 2004 Oct; 28(10):1043-51. PubMed ID: 15289016
[TBL] [Abstract][Full Text] [Related]
22. Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patients.
Scamardella F; Maconi M; Albertazzi L; Gamberi B; Gugliotta L; Brini M
Lab Hematol; 2006; 12(4):187-92. PubMed ID: 17118768
[TBL] [Abstract][Full Text] [Related]
23. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
[TBL] [Abstract][Full Text] [Related]
24. Circulating endothelial cells in patients with chronic lymphocytic leukemia.
Go RS; Jobe DA; Asp KE; Callister SM; Mathiason MA; Meyer LA; Bottner WA; Cole CE; Farnen JP; Frisby KA
Ann Hematol; 2008 May; 87(5):369-73. PubMed ID: 18193423
[TBL] [Abstract][Full Text] [Related]
25. CD31 density is a novel risk factor for patients with B-cell chronic lymphocytic leukaemia.
Mainou-Fowler T; Porteous A; Nicolle A; Proctor SJ; Anderson JJ; Summerfield G
Int J Oncol; 2008 Jul; 33(1):169-74. PubMed ID: 18575763
[TBL] [Abstract][Full Text] [Related]
26. Comparative flow cytometric evaluation of bcl-2 oncoprotein in CD5+ and CD5- B-cell lymphoid chronic leukemias.
Molica S; Mannella A; Crispino G; Dattilo A; Levato D
Haematologica; 1997; 82(5):555-9. PubMed ID: 9407720
[TBL] [Abstract][Full Text] [Related]
27. Functional and clinical relevance of CD44 variant isoform expression on B-cell chronic lymphocytic leukemia cells.
Zarcone D; De Rossi G; Tenca C; Marroni P; Mauro FR; Cerruti GM; Albi N; Fiorucci S; Velardi A; Grossi CE
Haematologica; 1998 Dec; 83(12):1088-98. PubMed ID: 9949626
[TBL] [Abstract][Full Text] [Related]
28. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
[TBL] [Abstract][Full Text] [Related]
29. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules.
Trentin L; Zambello R; Sancetta R; Facco M; Cerutti A; Perin A; Siviero M; Basso U; Bortolin M; Adami F; Agostini C; Semenzato G
Cancer Res; 1997 Nov; 57(21):4940-7. PubMed ID: 9354461
[TBL] [Abstract][Full Text] [Related]
30. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
31. Expression of erythropoietin receptor and in vitro functional effects of epoetins in B-cell malignancies.
Kokhaei P; Abdalla AO; Hansson L; Mikaelsson E; Kubbies M; Haselbeck A; Jernberg-Wiklund H; Mellstedt H; Osterborg A
Clin Cancer Res; 2007 Jun; 13(12):3536-44. PubMed ID: 17575216
[TBL] [Abstract][Full Text] [Related]
32. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
[TBL] [Abstract][Full Text] [Related]
33. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
[TBL] [Abstract][Full Text] [Related]
34. Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages.
Eksioğlu-Demiralp E; Alpdoğan O; Aktan M; Firatli T; Oztürk A; Budak T; Bayik M; Akoğlu T
Leukemia; 1996 Aug; 10(8):1331-9. PubMed ID: 8709639
[TBL] [Abstract][Full Text] [Related]
35. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
[TBL] [Abstract][Full Text] [Related]
36. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
[TBL] [Abstract][Full Text] [Related]
37. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
[TBL] [Abstract][Full Text] [Related]
38. Flow cytometric analysis of CD5+ B cells: a frame of reference for minimal residual disease analysis in chronic lymphocytic leukemia.
Gupta R; Jain P; Deo SV; Sharma A
Am J Clin Pathol; 2004 Mar; 121(3):368-72. PubMed ID: 15023041
[TBL] [Abstract][Full Text] [Related]
39. A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia.
Zucchetto A; Bomben R; Dal Bo M; Sonego P; Nanni P; Rupolo M; Bulian P; Dal Maso L; Del Poeta G; Del Principe MI; Degan M; Gattei V
J Cell Physiol; 2006 May; 207(2):354-63. PubMed ID: 16331666
[TBL] [Abstract][Full Text] [Related]
40. Intracellular IFN-gamma expression by CD3+/CD8+ cell subset in B-CLL patients correlates with stage of the disease.
Podhorecka M; Dmoszynska A; Rolinski J
Eur J Haematol; 2004 Jul; 73(1):29-35. PubMed ID: 15182335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
